(tert-Butoxycarbonyl)((4-(dimethyliminio)pyridin-1(4H)-yl)sulfonyl)amide

Catalog No. :
ACXCEW275
CAS No. :
2490268-91-0
Molecular Formula :
C12H19N3O4S
Molecular Weight :
301.37

IUPAC Name:tert-butyl (E)-((4-(dimethylamino)pyridin-1-ium-1-yl)sulfonyl)carbonimidate

(tert-Butoxycarbonyl)((4-(dimethyliminio)pyridin-1(4H)-yl)sulfonyl)amide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$266.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(tert-Butoxycarbonyl)((4-(dimethyliminio)pyridin-1(4H)-yl)sulfonyl)amide
IUPAC Nametert-butyl (E)-((4-(dimethylamino)pyridin-1-ium-1-yl)sulfonyl)carbonimidate
MDL No.MFCD24387682
Molecular FormulaC12H19N3O4S
Molecular Weight301.37
SMILESO=S(N(C=C1)C=CC1=[N+](C)C)([N-]C(OC(C)(C)C)=O)=O
InChI KeyKEQQONPVAQQBHG-UHFFFAOYSA-N
CAS No.2490268-91-0

Safety Data

Pictogram
FlammableHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H228-H315-H319
Precautionary Statement(s)
P210-P240-P241-P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P370+P378

Synthetic Route by SureRoute

1. ACXCEW275 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBPZ072 route compound structure diagram
    ACFBPZ07236809-75-3 In Stock
  2. Plus
  3. ACIQUB342 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACXCEW275 route product structure diagram
    ACXCEW2752490268-91-0
Inquiry

2. ACXCEW275 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBPZ072 route compound structure diagram
    ACFBPZ07236809-75-3 In Stock
  2. Plus
  3. ACIQUB342 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACXCEW275 route product structure diagram
    ACXCEW2752490268-91-0
Inquiry

Comments (0)